List of Excipients in API BUPIVACAINE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing BUPIVACAINE
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Renaissance Lakewood LLC | POSIMIR | bupivacaine | 49396-6601 | BENZYL ALCOHOL | |
Renaissance Lakewood LLC | POSIMIR | bupivacaine | 49396-6601 | SUCROSE ACETATE ISOBUTYRATE | |
INNOCOLL PHARMACEUTICALS | POSIMIR | bupivacaine | 51715-660 | BENZYL ALCOHOL | |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing BUPIVACAINE
Company | Ingredient | NDC | Excipient |
---|---|---|---|
HF Acquisition Co LLC DBA HealthFirst | bupivacaine hci | 51662-1581 | HYDROCHLORIC ACID |
HF Acquisition Co LLC DBA HealthFirst | bupivacaine hci | 51662-1581 | METHYLPARABEN |
HF Acquisition Co LLC DBA HealthFirst | bupivacaine hci | 51662-1581 | SODIUM CHLORIDE |
>Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for BUPIVACAINE
Excipient focus: ANHYDROUS DEXTROSE
BUPIVACAINE drug variants containing ANHYDROUS DEXTROSE
Company | Ingredient | NDC |
---|---|---|
B Braun Medical Inc | bupivacaine hydrochloride with dextrose | 0264-9379 |
Hospira Inc | bupivacaine hydrochloride in dextrose | 0409-1761 |
Hospira Inc | bupivacaine hydrochloride in dextrose | 0409-3613 |
>Company | >Ingredient | >NDC |
BUPIVACAINE drug variants not containing ANHYDROUS DEXTROSE
Company | Ingredient | NDC |
---|---|---|
Renaissance Lakewood LLC | bupivacaine | 49396-6601 |
INNOCOLL PHARMACEUTICALS | bupivacaine | 51715-660 |
Heron Therapeutics Inc | bupivacaine and meloxicam | 47426-301 |
>Company | >Ingredient | >NDC |
Excipient focus: ASCORBIC ACID
BUPIVACAINE drug variants containing ASCORBIC ACID
Company | Ingredient | NDC |
---|---|---|
Hospira Inc | bupivacaine hydrochloride and epinephrine | 0409-5738 |
Septodont Inc | bupivacaine hydrochloride and epinephrine bitartrate | 0362-0557 |
Septodont Inc | bupivacaine hydrochloride and epinephrine bitartrate | 0362-9011 |
>Company | >Ingredient | >NDC |
BUPIVACAINE drug variants not containing ASCORBIC ACID
Company | Ingredient | NDC |
---|---|---|
Renaissance Lakewood LLC | bupivacaine | 49396-6601 |
INNOCOLL PHARMACEUTICALS | bupivacaine | 51715-660 |
Heron Therapeutics Inc | bupivacaine and meloxicam | 47426-301 |
>Company | >Ingredient | >NDC |
Excipient focus: BENZYL ALCOHOL
BUPIVACAINE drug variants containing BENZYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Renaissance Lakewood LLC | bupivacaine | 49396-6601 |
INNOCOLL PHARMACEUTICALS | bupivacaine | 51715-660 |
>Company | >Ingredient | >NDC |
BUPIVACAINE drug variants not containing BENZYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Heron Therapeutics Inc | bupivacaine and meloxicam | 47426-301 |
HF Acquisition Co LLC DBA HealthFirst | bupivacaine hci | 51662-1581 |
HF Acquisition Co LLC DBA HealthFirst | bupivacaine hci and epinephrine | 51662-1399 |
>Company | >Ingredient | >NDC |
Excipient focus: CITRIC ACID MONOHYDRATE
BUPIVACAINE drug variants containing CITRIC ACID MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
HF Acquisition Co LLC DBA HealthFirst | bupivacaine hci and epinephrine | 51662-1399 |
REMEDYREPACK INC | bupivacaine hydrochloride and epinephrine bitartrate | 70518-2657 |
>Company | >Ingredient | >NDC |
BUPIVACAINE drug variants not containing CITRIC ACID MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
Renaissance Lakewood LLC | bupivacaine | 49396-6601 |
INNOCOLL PHARMACEUTICALS | bupivacaine | 51715-660 |
Heron Therapeutics Inc | bupivacaine and meloxicam | 47426-301 |
>Company | >Ingredient | >NDC |
Excipient focus: DETOSU/TRIETHYLENE GLYCOL/TRIETHYLENE GLYCOL POLYGLYCOLIDE COPOLYMER
BUPIVACAINE drug variants containing DETOSU/TRIETHYLENE GLYCOL/TRIETHYLENE GLYCOL POLYGLYCOLIDE COPOLYMER
Company | Ingredient | NDC |
---|---|---|
Heron Therapeutics Inc | bupivacaine and meloxicam | 47426-301 |
>Company | >Ingredient | >NDC |
BUPIVACAINE drug variants not containing DETOSU/TRIETHYLENE GLYCOL/TRIETHYLENE GLYCOL POLYGLYCOLIDE COPOLYMER
Company | Ingredient | NDC |
---|---|---|
Renaissance Lakewood LLC | bupivacaine | 49396-6601 |
INNOCOLL PHARMACEUTICALS | bupivacaine | 51715-660 |
HF Acquisition Co LLC DBA HealthFirst | bupivacaine hci | 51662-1581 |
>Company | >Ingredient | >NDC |
Excipient focus: DEXTROSE
BUPIVACAINE drug variants containing DEXTROSE
Company | Ingredient | NDC |
---|---|---|
Brookfield Pharmaceuticals LLC | bupivacaine hydrochloride | 71351-022 |
Huons Co Ltd | bupivacaine hydrochloride | 73293-0002 |
>Company | >Ingredient | >NDC |
BUPIVACAINE drug variants not containing DEXTROSE
Company | Ingredient | NDC |
---|---|---|
Renaissance Lakewood LLC | bupivacaine | 49396-6601 |
INNOCOLL PHARMACEUTICALS | bupivacaine | 51715-660 |
Heron Therapeutics Inc | bupivacaine and meloxicam | 47426-301 |
>Company | >Ingredient | >NDC |
Excipient focus: DIMETHYL SULFOXIDE
BUPIVACAINE drug variants containing DIMETHYL SULFOXIDE
Company | Ingredient | NDC |
---|---|---|
Heron Therapeutics Inc | bupivacaine and meloxicam | 47426-301 |
>Company | >Ingredient | >NDC |
BUPIVACAINE drug variants not containing DIMETHYL SULFOXIDE
Company | Ingredient | NDC |
---|---|---|
Renaissance Lakewood LLC | bupivacaine | 49396-6601 |
INNOCOLL PHARMACEUTICALS | bupivacaine | 51715-660 |
HF Acquisition Co LLC DBA HealthFirst | bupivacaine hci | 51662-1581 |
>Company | >Ingredient | >NDC |
Excipient focus: EDETATE CALCIUM DISODIUM
BUPIVACAINE drug variants containing EDETATE CALCIUM DISODIUM
Company | Ingredient | NDC |
---|---|---|
Septodont Inc | bupivacaine hydrochloride and epinephrine bitartrate | 0362-0557 |
Septodont Inc | bupivacaine hydrochloride and epinephrine bitartrate | 0362-9011 |
Henry Schein Inc | bupivacaine hydrochloride and epinephrine bitartrate | 0404-9908 |
>Company | >Ingredient | >NDC |
BUPIVACAINE drug variants not containing EDETATE CALCIUM DISODIUM
Company | Ingredient | NDC |
---|---|---|
Renaissance Lakewood LLC | bupivacaine | 49396-6601 |
INNOCOLL PHARMACEUTICALS | bupivacaine | 51715-660 |
Heron Therapeutics Inc | bupivacaine and meloxicam | 47426-301 |
>Company | >Ingredient | >NDC |
Excipient focus: HYDROCHLORIC ACID
BUPIVACAINE drug variants containing HYDROCHLORIC ACID
Company | Ingredient | NDC |
---|---|---|
HF Acquisition Co LLC DBA HealthFirst | bupivacaine hci | 51662-1581 |
HF Acquisition Co LLC DBA HealthFirst | bupivacaine hci and epinephrine | 51662-1399 |
HF Acquisition Co LLC DBA HealthFirst | bupivacaine hcl | 51662-1592 |
>Company | >Ingredient | >NDC |
BUPIVACAINE drug variants not containing HYDROCHLORIC ACID
Company | Ingredient | NDC |
---|---|---|
Renaissance Lakewood LLC | bupivacaine | 49396-6601 |
INNOCOLL PHARMACEUTICALS | bupivacaine | 51715-660 |
Heron Therapeutics Inc | bupivacaine and meloxicam | 47426-301 |
>Company | >Ingredient | >NDC |
Excipient focus: MALEIC ACID
BUPIVACAINE drug variants containing MALEIC ACID
Company | Ingredient | NDC |
---|---|---|
Heron Therapeutics Inc | bupivacaine and meloxicam | 47426-301 |
>Company | >Ingredient | >NDC |
BUPIVACAINE drug variants not containing MALEIC ACID
Company | Ingredient | NDC |
---|---|---|
Renaissance Lakewood LLC | bupivacaine | 49396-6601 |
INNOCOLL PHARMACEUTICALS | bupivacaine | 51715-660 |
HF Acquisition Co LLC DBA HealthFirst | bupivacaine hci | 51662-1581 |
>Company | >Ingredient | >NDC |
Excipient focus: METHYLPARABEN
BUPIVACAINE drug variants containing METHYLPARABEN
Company | Ingredient | NDC |
---|---|---|
HF Acquisition Co LLC DBA HealthFirst | bupivacaine hci | 51662-1581 |
HF Acquisition Co LLC DBA HealthFirst | bupivacaine hci and epinephrine | 51662-1399 |
HF Acquisition Co LLC DBA HealthFirst | bupivacaine hcl | 51662-1592 |
>Company | >Ingredient | >NDC |
BUPIVACAINE drug variants not containing METHYLPARABEN
Company | Ingredient | NDC |
---|---|---|
Renaissance Lakewood LLC | bupivacaine | 49396-6601 |
INNOCOLL PHARMACEUTICALS | bupivacaine | 51715-660 |
Heron Therapeutics Inc | bupivacaine and meloxicam | 47426-301 |
>Company | >Ingredient | >NDC |
Excipient focus: MONOTHIOGLYCEROL
BUPIVACAINE drug variants containing MONOTHIOGLYCEROL
Company | Ingredient | NDC |
---|---|---|
Septodont Inc | bupivacaine hydrochloride and epinephrine bitartrate | 0362-0557 |
Septodont Inc | bupivacaine hydrochloride and epinephrine bitartrate | 0362-9011 |
Henry Schein Inc | bupivacaine hydrochloride and epinephrine bitartrate | 0404-9908 |
>Company | >Ingredient | >NDC |
BUPIVACAINE drug variants not containing MONOTHIOGLYCEROL
Company | Ingredient | NDC |
---|---|---|
Renaissance Lakewood LLC | bupivacaine | 49396-6601 |
INNOCOLL PHARMACEUTICALS | bupivacaine | 51715-660 |
Heron Therapeutics Inc | bupivacaine and meloxicam | 47426-301 |
>Company | >Ingredient | >NDC |
Excipient focus: NITROGEN
BUPIVACAINE drug variants containing NITROGEN
Company | Ingredient | NDC |
---|---|---|
Brookfield Pharmaceuticals LLC | bupivacaine hydrochloride | 71351-022 |
Huons Co Ltd | bupivacaine hydrochloride | 73293-0002 |
>Company | >Ingredient | >NDC |
BUPIVACAINE drug variants not containing NITROGEN
Company | Ingredient | NDC |
---|---|---|
Renaissance Lakewood LLC | bupivacaine | 49396-6601 |
INNOCOLL PHARMACEUTICALS | bupivacaine | 51715-660 |
Heron Therapeutics Inc | bupivacaine and meloxicam | 47426-301 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM CHLORIDE
BUPIVACAINE drug variants containing SODIUM CHLORIDE
Company | Ingredient | NDC |
---|---|---|
HF Acquisition Co LLC DBA HealthFirst | bupivacaine hci | 51662-1581 |
HF Acquisition Co LLC DBA HealthFirst | bupivacaine hci and epinephrine | 51662-1399 |
HF Acquisition Co LLC DBA HealthFirst | bupivacaine hcl | 51662-1592 |
>Company | >Ingredient | >NDC |
BUPIVACAINE drug variants not containing SODIUM CHLORIDE
Company | Ingredient | NDC |
---|---|---|
Renaissance Lakewood LLC | bupivacaine | 49396-6601 |
INNOCOLL PHARMACEUTICALS | bupivacaine | 51715-660 |
Heron Therapeutics Inc | bupivacaine and meloxicam | 47426-301 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
BUPIVACAINE drug variants containing SODIUM HYDROXIDE
Company | Ingredient | NDC |
---|---|---|
HF Acquisition Co LLC DBA HealthFirst | bupivacaine hci | 51662-1581 |
HF Acquisition Co LLC DBA HealthFirst | bupivacaine hci and epinephrine | 51662-1399 |
HF Acquisition Co LLC DBA HealthFirst | bupivacaine hcl | 51662-1592 |
>Company | >Ingredient | >NDC |
BUPIVACAINE drug variants not containing SODIUM HYDROXIDE
Company | Ingredient | NDC |
---|---|---|
Renaissance Lakewood LLC | bupivacaine | 49396-6601 |
INNOCOLL PHARMACEUTICALS | bupivacaine | 51715-660 |
Heron Therapeutics Inc | bupivacaine and meloxicam | 47426-301 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM LACTATE
BUPIVACAINE drug variants containing SODIUM LACTATE
Company | Ingredient | NDC |
---|---|---|
Septodont Inc | bupivacaine hydrochloride and epinephrine bitartrate | 0362-0557 |
Septodont Inc | bupivacaine hydrochloride and epinephrine bitartrate | 0362-9011 |
Henry Schein Inc | bupivacaine hydrochloride and epinephrine bitartrate | 0404-9908 |
>Company | >Ingredient | >NDC |
BUPIVACAINE drug variants not containing SODIUM LACTATE
Company | Ingredient | NDC |
---|---|---|
Renaissance Lakewood LLC | bupivacaine | 49396-6601 |
INNOCOLL PHARMACEUTICALS | bupivacaine | 51715-660 |
Heron Therapeutics Inc | bupivacaine and meloxicam | 47426-301 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM METABISULFITE
BUPIVACAINE drug variants containing SODIUM METABISULFITE
Company | Ingredient | NDC |
---|---|---|
HF Acquisition Co LLC DBA HealthFirst | bupivacaine hci and epinephrine | 51662-1399 |
Hospira Inc | bupivacaine hydrochloride and epinephrine | 0409-5738 |
Septodont Inc | bupivacaine hydrochloride and epinephrine bitartrate | 0362-0557 |
>Company | >Ingredient | >NDC |
BUPIVACAINE drug variants not containing SODIUM METABISULFITE
Company | Ingredient | NDC |
---|---|---|
Renaissance Lakewood LLC | bupivacaine | 49396-6601 |
INNOCOLL PHARMACEUTICALS | bupivacaine | 51715-660 |
Heron Therapeutics Inc | bupivacaine and meloxicam | 47426-301 |
>Company | >Ingredient | >NDC |
Excipient focus: SUCROSE ACETATE ISOBUTYRATE
BUPIVACAINE drug variants containing SUCROSE ACETATE ISOBUTYRATE
Company | Ingredient | NDC |
---|---|---|
Renaissance Lakewood LLC | bupivacaine | 49396-6601 |
INNOCOLL PHARMACEUTICALS | bupivacaine | 51715-660 |
>Company | >Ingredient | >NDC |
BUPIVACAINE drug variants not containing SUCROSE ACETATE ISOBUTYRATE
Company | Ingredient | NDC |
---|---|---|
Heron Therapeutics Inc | bupivacaine and meloxicam | 47426-301 |
HF Acquisition Co LLC DBA HealthFirst | bupivacaine hci | 51662-1581 |
HF Acquisition Co LLC DBA HealthFirst | bupivacaine hci and epinephrine | 51662-1399 |
>Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
BUPIVACAINE drug variants containing TRIACETIN
Company | Ingredient | NDC |
---|---|---|
Heron Therapeutics Inc | bupivacaine and meloxicam | 47426-301 |
>Company | >Ingredient | >NDC |
BUPIVACAINE drug variants not containing TRIACETIN
Company | Ingredient | NDC |
---|---|---|
Renaissance Lakewood LLC | bupivacaine | 49396-6601 |
INNOCOLL PHARMACEUTICALS | bupivacaine | 51715-660 |
HF Acquisition Co LLC DBA HealthFirst | bupivacaine hci | 51662-1581 |
>Company | >Ingredient | >NDC |
Excipient focus: WATER
BUPIVACAINE drug variants containing WATER
Company | Ingredient | NDC |
---|---|---|
HF Acquisition Co LLC DBA HealthFirst | bupivacaine hci | 51662-1581 |
Hikma Pharmaceuticals USA Inc | bupivacaine hydrochloride | 0143-9328 |
Hikma Pharmaceuticals USA Inc | bupivacaine hydrochloride | 0143-9330 |
>Company | >Ingredient | >NDC |
BUPIVACAINE drug variants not containing WATER
Company | Ingredient | NDC |
---|---|---|
Renaissance Lakewood LLC | bupivacaine | 49396-6601 |
INNOCOLL PHARMACEUTICALS | bupivacaine | 51715-660 |
Heron Therapeutics Inc | bupivacaine and meloxicam | 47426-301 |
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.